Skip to content

Robocentric

Artificial intelligence, robotics, human body biotech, mass-scale outer space tech

  • The Future
  • Plan
  • Directives
  • Investors
  • Donation
  • Merchandise
  • Podcast
  • Social
  • Livestream
  • Contact
  • About

Author: Allen Young

Robocentric CEO 

The Future: How artificial intelligence, robotics, human body biotech, and mass-scale outer space tech will alter the human reality

May 26, 2022May 26, 2022 Allen Young

Saying that The Future is wild is a gross understatement: The Future is absolutely insane, just the way it should

Read more
Robocentric CEO 

About Robocentric (5/26/2022)

May 26, 2022May 26, 2022 Allen Young

Transhumanize and posthumanize humankind—through advancing the science, technology, and capitalism of artificial intelligence, robotics, human immortality biotech, human genetic engineering,

Read more

Robocentric status

Robocentric CEO, Allen Young, the transhumanistic Asian-American man, is currently working on securing funding for Robocentric, and developing Robocentric's first high-tech products in AI and robotics.

For more information about Robocentric's near-term business plan, visit Robocentric.com/Plan.

For more information about Robocentric's overall, long-term business plan, visit Robocentric.com/Future.

Robocentric artificial intelligence development course

Robocentric's initial AI focus is on developing and commercializing recognitive AI.

For more information on Robocentric's overall AI development and commercialization strategy, read The Future, the book, available at Robocentric.com/Future.

Robocentric robotics economic goal

Robocentric aims to double the U.S. annual GDP to US$50 trillion via robotizing the U.S. national economy.

For more information on Robocentric's overall robotics development and commercialization strategy, read The Future, the book, available at Robocentric.com/Future.

Robocentric biotech categories

Robocentric develops and commercializes scanner, modeler, designer, synthesizer, replacer, and applied biotechnologies.

For more information on Robocentric's overall biotech development and commercialization strategy, read The Future, the book, available at Robocentric.com/Future.

Constant-1g-acceleration spaceship travel times

The average travel time between Earth and Venus is 3.05 days by an artificial nuclear-fusion reactor propelled constant-1g-acceleration spaceship.

The average travel time between Earth and Saturn is 8.84 days by an artificial nuclear-fusion reactor propelled constant-1g-acceleration spaceship.

The average travel time between Earth and Uranus is 11.92 days by an artificial nuclear-fusion reactor propelled constant-1g-acceleration spaceship.

The average travel time between Earth and Neptune is 15.78 days by an artificial nuclear-fusion reactor propelled constant-1g-acceleration spaceship.

For more information on Robocentric's overall outer-space tech development and commercialization strategy, read The Future, the book, available at Robocentric.com/Future.

Venus Planetary Artificial-Surface Ring (PASuR) matter requirements

In order to build the first mass-scale outer space human habitat on Venus, over 2.63517 x 1018 kg of iron and 2.06134 x 1018 kg of artificial nuclear-fusion fuel are required.

For more information on Robocentric's overall outer-space tech development and commercialization strategy, read The Future, the book, available at Robocentric.com/Future.

Copyright © 2022 Robocentric. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.